Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

RATIONALE Reducing the global burden of sepsis, a recognized global health challenge, requires comprehensive data on the incidence and mortality on a global scale. OBJECTIVES To estimate the worldwide incidence and mortality of sepsis and identify knowledge gaps based on available evidence from observational studies. METHODS We systematically searched 15 international citation databases for population-level estimates of sepsis incidence rates and fatality in adult populations using consensus criteria and published in the last 36 years. MEASUREMENTS AND MAIN RESULTS The search yielded 1,553 reports from 1979 to 2015, of which 45 met our criteria. A total of 27 studies from seven high-income countries provided data for metaanalysis. For these countries, the population incidence rate was 288 (95% confidence interval [CI], 215-386; τ = 0.55) for hospital-treated sepsis cases and 148 (95% CI, 98-226; τ = 0.99) for hospital-treated severe sepsis cases per 100,000 person-years. Restricted to the last decade, the incidence rate was 437 (95% CI, 334-571; τ = 0.38) for sepsis and 270 (95% CI, 176-412; τ = 0.60) for severe sepsis cases per 100,000 person-years. Hospital mortality was 17% for sepsis and 26% for severe sepsis during this period. There were no population-level sepsis incidence estimates from lower-income countries, which limits the prediction of global cases and deaths. However, a tentative extrapolation from high-income country data suggests global estimates of 31.5 million sepsis and 19.4 million severe sepsis cases, with potentially 5.3 million deaths annually. CONCLUSIONS Population-level epidemiologic data for sepsis are scarce and nonexistent for low- and middle-income countries. Our analyses underline the urgent need to implement global strategies to measure sepsis morbidity and mortality, particularly in low- and middle-income countries.

[1]  W. Knaus,et al.  DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR INNOVATIVE THERAPIES IN SEPIS , 1992 .

[2]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[3]  M. Gondo,et al.  Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, west Africa. , 1993, The Journal of infectious diseases.

[4]  F. Wabwire-mangen,et al.  A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[5]  J. Tokars,et al.  A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. , 2000, The Journal of infectious diseases.

[6]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[7]  Derek C. Angus,et al.  Epidemiology of sepsis: An update , 2001, Critical care medicine.

[8]  M. Molyneux,et al.  Bacteraemia and mortality among adult medical admissions in Malawi--predominance of non-typhi salmonellae and Streptococcus pneumoniae. , 2001, The Journal of infection.

[9]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[10]  G. Oster,et al.  Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[12]  Guido Knapp,et al.  Improved tests for a random effects meta‐regression with a single covariate , 2003, Statistics in medicine.

[13]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[14]  H. Flaatten Epidemiology of sepsis in Norway in 1999 , 2004, Critical care.

[15]  Epidemiology of hospitalizations for sepsis in Rhode Island, 1990-2002. , 2004, Medicine and health, Rhode Island.

[16]  L. Schofield,et al.  Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.

[17]  B. Nwoke,et al.  Concomitant bacteria in the blood of malaria patients in Owerri, southeastern Nigeria. , 2009, Tanzania health research bulletin.

[18]  J. Iñigo,et al.  Epidemiología y costes de la sepsis grave en Madrid.Estudio de altas hospitalarias , 2006 .

[19]  S. Zanotti-Cavazzoni Epidemiology of Sepsis in Victoria, Australia , 2006 .

[20]  C. Camargo,et al.  National study of emergency department visits for sepsis, 1992 to 2001. , 2006, Annals of emergency medicine.

[21]  A. Sarría-Santamera,et al.  [Epidemiology and costs of severe sepsis in Madrid. A hospital discharge study]. , 2006, Medicina intensiva.

[22]  F. Gordo,et al.  Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward* , 2007, Critical care medicine.

[23]  Sumita Sinha,et al.  Seasonal variation in the epidemiology of sepsis* , 2007, Critical care medicine.

[24]  K. Jahnz-Różyk,et al.  Epidemiology of sepsis , 2008 .

[25]  F. Ballester,et al.  Epidemiology of Sepsis in the Valencian Community (Spain), 1995–2004 , 2008, Infection Control & Hospital Epidemiology.

[26]  S. Zanotti-Cavazzoni,et al.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003 , 2008 .

[27]  Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward , 2008 .

[28]  D. Angus,et al.  Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. , 2008, American journal of respiratory and critical care medicine.

[29]  A. Melamed,et al.  The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data , 2009, Critical care.

[30]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[31]  G. Rubenfeld,et al.  Critical care and the global burden of critical illness in adults , 2010, The Lancet.

[32]  F. Sjöberg,et al.  Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: Difficulties with methods and interpretation of results , 2010, Critical care medicine.

[33]  D. Maher,et al.  Septicaemia in a population‐based HIV clinical cohort in rural Uganda, 1996–2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy , 2010, Tropical medicine & international health : TM & IH.

[34]  C. Seymour,et al.  Marital status and the epidemiology and outcomes of sepsis. , 2010, Chest.

[35]  Alan S. Go,et al.  Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[36]  Chin-Li Lu,et al.  Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. , 2010, Chest.

[37]  Allen C Cheng,et al.  Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians , 2011, The Medical journal of Australia.

[38]  Christopher J. Czura,et al.  “Merinoff Symposium 2010: Sepsis”—Speaking with One Voice , 2011, Molecular medicine.

[39]  M. J. Hall,et al.  Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. , 2011, NCHS data brief.

[40]  E. Stranges,et al.  Septicemia in U.S. Hospitals, 2009 , 2011 .

[41]  T. Rea,et al.  Severe Sepsis In Prehospital Emergency Care: Analysis Of Incidence, Care, And Outcome , 2012, ATS 2012.

[42]  Donald M Yealy,et al.  Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. , 2012, American journal of respiratory and critical care medicine.

[43]  S. Zanotti-Cavazzoni,et al.  Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007) , 2012 .

[44]  T. Lagu,et al.  What is the best method for estimating the burden of severe sepsis in the United States? , 2012, Journal of critical care.

[45]  Matthew Taecker Hospitalizations, Costs, and Outcomes of Severe Sepsis in the United States 2003 to 2007 , 2012 .

[46]  T. Lagu,et al.  Variation in the care of septic shock: the impact of patient and hospital characteristics. , 2012, Journal of critical care.

[47]  B. Friedman,et al.  Trends in Septicemia Hospitalizations and Readmissions in Selected HCUP States, 2005 and 2010 , 2013 .

[48]  Kevin J. Tracey,et al.  Sepsis definitions: time for change , 2013, The Lancet.

[49]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[50]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[51]  M. Mikkelsen,et al.  Severe Sepsis Cohorts Derived From Claims-Based Strategies Appear to be Biased Toward a More Severely Ill Patient Population* , 2013, Critical care medicine.

[52]  B. Carr,et al.  Benchmarking the Incidence and Mortality of Severe Sepsis in the United States* , 2013, Critical care medicine.

[53]  G. Escobar,et al.  Hospital deaths in patients with sepsis from 2 independent cohorts. , 2014, JAMA.

[54]  Cynthia D Mulrow,et al.  Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change , 2014, Annals of Internal Medicine.

[55]  Shruti Gohil,et al.  Regulatory mandates for sepsis care--reasons for caution. , 2014, The New England journal of medicine.

[56]  T. López-Cuadrado,et al.  Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011) , 2014, BMC Infectious Diseases.

[57]  Theodore J. Iwashyna,et al.  Declining case fatality rates for severe sepsis: good data bring good news with ambiguous implications. , 2014, JAMA.

[58]  Nobhojit Roy,et al.  Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[59]  R. Bellomo,et al.  Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. , 2014, JAMA.

[60]  Hassane Njimi,et al.  Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. , 2014, The Lancet. Respiratory medicine.

[61]  Renda Soylemez Wiener,et al.  Two Decades of Mortality Trends Among Patients With Severe Sepsis: A Comparative Meta-Analysis* , 2014, Critical care medicine.

[62]  Valérie D'Acremont,et al.  Beyond malaria--causes of fever in outpatient Tanzanian children. , 2014, The New England journal of medicine.

[63]  S. Opal,et al.  Sepsis: a roadmap for future research. , 2015, The Lancet. Infectious diseases.

[64]  Namrata Prasad,et al.  Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review , 2015, PloS one.

[65]  J. Hallas,et al.  Incidence Rate of Community-Acquired Sepsis Among Hospitalized Acute Medical Patients—A Population-Based Survey* , 2015, Critical care medicine.

[66]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[67]  T. Lagu,et al.  A Population-Based Study , 2015 .

[68]  P. Schlattmann,et al.  Global burden of sepsis: a systematic review , 2015, Critical Care.

[69]  Michael Bailey,et al.  Systemic inflammatory response syndrome criteria in defining severe sepsis. , 2015, The New England journal of medicine.

[70]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.